聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 20 分钟 5 秒 前

Impax and DURECT Sign a $63 Million Agreement to Develop and Commercialize DURECT’s ELADUR(R) Pain Patch

周二, 01/07/2014 - 16:24
HAYWARD, Calif. & CUPERTINO, Calif.--(Healthcare Sales & Marketing Network)--Impax Laboratories, Inc.(IPXL) and DURECT Corporation (DRRX) announced today that they have entered into an agreement granting Impax the exclusive worldwide rights to develop and ...
Biopharmaceuticals, Drug Delivery
Impax Laboratories, DURECT Corp, transdermal, bupivacaine

MRI Interventions' ClearPoint System Utilized at Cincinnati Children's Hospital for Neurosurgical Shunt Placement

周二, 01/07/2014 - 16:20
IRVINE, Calif., Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- MRI Interventions, Inc. (MRIC) today announced that the first real-time MRI-guided neurosurgical shunt placement using the company's ClearPoint(R) Neuro Intervention System has been ...
Devices, Neurosurgery, Surgery, Radiology, Personnel
MRI Interventions, ClearPoint, ClearTrace, SmartFlow

KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing

周二, 01/07/2014 - 16:17
Lam Joins KaloBios with Over 28 Years Biopharmaceutical Manufacturing Experience SOUTH SAN FRANCISCO, Calif., Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- KaloBios Pharmaceuticals, Inc. (KBIO) today announced the appointment of Harry Lam, ...
Biopharmaceuticals, Personnel
KaloBios Pharmaceuticals, monoclonal antibodies, monoclonal antibody

Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing

周二, 01/07/2014 - 16:14
Funds Will Expand Clinical Development of Company's Controlled Cellular Immunotherapies HOUSTON, Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Bellicum Pharmaceuticals, Inc. announced today that it has completed a second and final closing o...
Biopharmaceuticals, Oncology, Venture Capital
Bellicum Pharmaceuticals, CaspaCIDe, Graft versus Host Disease

AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources

周二, 01/07/2014 - 16:10
WALTHAM, Mass., Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- AMAG Pharmaceuticals, Inc. (AMAG) today announced the appointment of Elizabeth Bolgiano as senior vice president of human resources. Ms. Bolgiano brings more than 20 years of experie...
Biopharmaceuticals, Personnel
AMAG Pharmaceuticals, eraheme, ferumoxytol

BD Acquires Alverix, Inc.

周二, 01/07/2014 - 16:08
Advances BD Diagnostics' Point-of-Care Strategy FRANKLIN LAKES, N.J., Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, announced today that it has acquired ...
Devices, Diagnostics, Mergers & Acquisitions
BD , BD Diagnostics, Alverix, Veritor System

Cempra, Inc. Names David Moore as Chief Commercial Officer to Manage Commercial Development and Launch of Solithromycin and Taksta(TM)

周二, 01/07/2014 - 16:04
CHAPEL HILL, N.C., Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Cempra, Inc. (CEMP) today announced the appointment of David Moore as executive vice president and chief commercial officer (CCO) to manage the commercial development and launch o...
Biopharmaceuticals, Personnel
Cempra, Solithromycin, TAKSTA

Zynex Appoints Vice President of Sales for NeuroDiagnostics Division

周二, 01/07/2014 - 15:44
LONE TREE, CO--(Healthcare Sales & Marketing Network) - Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation, and neurological diagnosis, announced today that it has appointed James C...
Devices, Neurology, Personnel
Zynex, Zynex NeuroDiagnostics, electrotherapy

Navidea Biopharmaceuticals Expands Lymphoseek(R) Global Commercialization Efforts

周二, 01/07/2014 - 15:38
Company Enters into Distribution Agreement for Taiwan DUBLIN, Ohio--(Healthcare Sales & Marketing Network)--Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced tod...
Biopharmaceuticals, Radiology, Distribution
Navidea Biopharmaceuticals, Global Medical Solutions Taiwan, Lymphoseek

Stereotaxis Completes Clinical Trial of Vdrive(TM) With V-Loop(TM) System

周二, 01/07/2014 - 15:30
ST. LOUIS, Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Stereotaxis, Inc. (STXS) announced today that it has completed the clinical trial required for FDA clearance of the Company's Vdrive(TM) Robotic Navigation System with V-Loop(TM) Circular...
Devices, Cardiology
Stereotaxis, Vdrive, Robotic Navigation System, V-Loop, Circular Catheter

Velocity Pharmaceutical Development Announces Appointment of Stuart Sedlack as Senior Vice President, Business Development

周二, 01/07/2014 - 13:31
SOUTH SAN FRANCISCO, Calif., Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Velocity Pharmaceutical Development (VPD) today announced a key addition to the Company's management team with the appointment of Stuart Sedlack as Senior Vice Presiden...
Biopharmaceuticals, Personnel
Velocity Pharmaceutical Development

Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension

周二, 01/07/2014 - 13:27
Health Economic Analysis Published in the Journal of Hypertension MINNEAPOLIS, Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- CVRx, Inc., a privately held medical device company, today announced findings from a health-economic analysis publi...
Devices, Cardiology
CVRx, Barostim, Barostim neo, drug resistant hypertension, hypertension

DySIS Medical Appoints Robert Cascella as Chairman

周二, 01/07/2014 - 13:18
EDINBURGH, Scotland--(Healthcare Sales & Marketing Network)--DySIS Medical Ltd, a medical devices company active within Women’s Health, today announces that Robert Cascella has joined as Chairman of the board of directors of the Company effective January 2...
Devices, Personnel
DySIS Medical, colposcopy, spectral imaging, biophotonic

Shield Therapeutics' ST10 Delivers Robust Results Meeting both Primary and Secondary Endpoints in the Pivotal AEGIS Phase 3 Programme for the Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease

周二, 01/07/2014 - 13:09
ST10 strongly demonstrates potential to be (1) the only effective oral treatment for ferrous intolerant IDA patients and (2) an effective alternative to intravenous iron treatment LONDON, January 7, 2014 -- (Healthcare Sales & Marketing Network) -- Shi...
Biopharmaceuticals, Gastroenterology
Shield Therapeutics, ST10, iron deficiency anaemia, inflammatory bowel disease

Microbix Sues Novartis for Infringement of its VIRUSMAX(R) Patent

周一, 01/06/2014 - 22:50
TORONTO, Jan. 6, 2014 (Healthcare Sales & Marketing Network) - Microbix Biosystems Inc. (MBX.TO) ("Microbix" or the "Company"), an innovator of biological products and technologies, announced today it has commenced a patent litigation ...
Biopharmaceuticals, Litigation
Microbix Biosystems, Novartis, VIRUSMAX, vaccine

Gilead Sciences’ Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire

周一, 01/06/2014 - 22:48
FOSTER CITY, Calif.--(Healthcare Sales & Marketing Network)--Gilead Sciences, Inc. (GILD) today announced that Kevin Young CBE, Executive Vice President, Commercial Operations, has informed the company of his decision to retire, effective February 4th. Mr....
Biopharmaceuticals, Personnel
Gilead Sciences

FDA Reclassifies ECP Devices for Refractory Angina as Class II

周一, 01/06/2014 - 22:45
Requires Premarket Approval for ECP Devices for Other Intended Uses WESTBURY, N.Y., Jan. 6, 2014 -- (Healthcare Sales & Marketing Network) -- Vasomedical, Inc. ("Vasomedical") (VASO), a diversified medical technology company specializing in t...
Devices, Cardiology, FDA
Vasomedical, EECP, External Counterpulsation

Champions Oncology Names Angela Davies, M.D., Chief Medical Officer

周一, 01/06/2014 - 21:26
HACKENSACK, N.J., Jan. 6, 2014 -- (Healthcare Sales & Marketing Network) -- Champions Oncology (CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today annou...
Biopharmaceuticals, Personalized Medicine, Personnel
Champions Oncology, TumorGraft

Tekmira Announces Strategic Reorganization to Strengthen Leadership Team

周一, 01/06/2014 - 21:19
Dr. Michael Abrams Appointed Chief Discovery Officer Dr. Ian MacLachlan Named Chief Technical Officer VANCOUVER, British Columbia, Jan. 6, 2014 -- (Healthcare Sales & Marketing Network) -- Tekmira Pharmaceuticals Corporation (TKMR) (TKM.TO), a leadin...
Biopharmaceuticals, Personnel
Tekmira Pharmaceuticals, RNAi therapeutics

Stryker and NeuroLogica Partner to Provide Surgical Navigation with the BodyTom(R) Portable CT Scanner

周一, 01/06/2014 - 20:00
KALAMAZOO, Mich. and DANVERS, Mass., Jan. 6, 2014 -- (Healthcare Sales & Marketing Network) -- Stryker Corporation and NeuroLogica, a subsidiary of Samsung Electronics America Inc., announced an exclusive partnership agreement in which Stryker will promot...
Devices, Orthopaedic, Neurosurgery, Radiology
Stryker, NeuroLogica , BodyTom, computed tomography, Surgical Navigation

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong